The approval obtained by Theradis Pharma in order to be recognised as a Pharmaceutical Company implies having premises that correspond perfectly to the rigorous specifications required. Theradis Pharma's technical facilities correspond to the regulatory requirements (BPF, BPD and BPC) that take into account the storage of Investigational Medicinal Products.
Taking advantage of the experience that has been acquired during the running of many clinical trials, Theradis Pharma has installed it’s facilities using a rational organisation of space, allowing the efficient management of material necessary for clinical trials as well as the preparation of the documents required for these studies
With a storage potential of 2000m3, Theradis Pharma proposes storage at
- an ambient T°
- at +2 / +8°C
- - 20°C
- - 80°C
The Investigational Medicinal Products are stored in grey rooms (isothermic rooms constructed from panels of polyurethane) blinded and permanently temperature and hygrometry controlled . The storage volume available is 350 m3 on shelves and racks.
Secure and confidential dedicated zones are reserved for each project depending upon the product that is stocked.
The establishment and identification of each specific area, reception, storage or distribution, allows an efficient control of the incoming and outgoing flow.
The whole of the premises are protected by a security system that detects all abnormalities, such as attempts to break in, fire, power cuts, temperature variations and hygrometry that fall outside the limits that have been predefined per zone (24h/24, 7days a week). This system is linked to a remote monitoring company and this ensures immediate intervention.